Search details
1.
Primary antiphospholipid syndrome as a cause of impaired left ventricular diastolic function: experience from a Serbian cohort.
Clin Exp Rheumatol
; 41(1): 103-109, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-35485420
2.
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
Eur Heart J
; 38(9): 648-660, 2017 Mar 01.
Article
in English
| MEDLINE | ID: mdl-28025189
3.
The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: A cross-sectional study.
Int J Clin Pract
; 71(10)2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28869702
4.
Associations of GSTM1*0 and GSTA1*A genotypes with the risk of cardiovascular death among hemodialyses patients.
BMC Nephrol
; 15: 12, 2014 Jan 14.
Article
in English
| MEDLINE | ID: mdl-24423050
5.
Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
Isr Med Assoc J
; 16(3): 162-7, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24761704
6.
The 'peptide for life' initiative in the emergency department study.
ESC Heart Fail
; 11(2): 672-680, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38093494
7.
The role of serum VCAM-1 and TNF-α as predictors of mortality and morbidity in patients with chronic heart failure.
J Clin Lab Anal
; 27(2): 105-12, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23349048
8.
Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension.
Medicine (Baltimore)
; 102(22): e33941, 2023 Jun 02.
Article
in English
| MEDLINE | ID: mdl-37266607
9.
Rationale and design of the ESC Heart Failure III Registry - Implementation and discovery.
Eur J Heart Fail
; 25(12): 2316-2330, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37990135
10.
Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure.
J Card Fail
; 18(6): 493-501, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22633308
11.
Potential drug-drug interactions associated with clinical and laboratory findings at hospital admission.
Int J Clin Pharm
; 42(1): 150-157, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31865593
12.
Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
Curr Med Res Opin
; 35(11): 1873-1883, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31328967
13.
Glutathione Transferase P1 Polymorphism Might Be a Risk Determinant in Heart Failure.
Dis Markers
; 2019: 6984845, 2019.
Article
in English
| MEDLINE | ID: mdl-31275451
14.
Uric acid and gamma-glutamyl transferase activity are associated with left ventricular remodeling indices in patients with chronic heart failure.
Rev Esp Cardiol (Engl Ed)
; 67(8): 632-42, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-25037542
15.
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
Cardiol J
; 21(3): 265-72, 2014.
Article
in English
| MEDLINE | ID: mdl-23990195
16.
c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma.
Biomed Pharmacother
; 67(5): 445-9, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23582793
17.
El ácido úrico y la actividad de gammaglutamil transferasa se asocian a los índices de remodelado ventricular izquierdo en pacientes con insuficiencia cardiaca crónica / Uric acid and gamma-glutamyl transferase activity are associated with left ventricular remodeling indices in patients with chronic heart failure
Rev. esp. cardiol. (Ed. impr.)
; 67(8): 632-642, ago. 2014. ilus, tab
Article
in Spanish
| IBECS (Spain) | ID: ibc-125423
18.
Markers of oxidative damage in chronic heart failure: role in disease progression.
Redox Rep
; 13(3): 109-16, 2008.
Article
in English
| MEDLINE | ID: mdl-18544228
19.
[Dr Andreas Gruentzig--more than 30 years of the genius vision in therapy of coronary artery disease].
Vojnosanit Pregl
; 69(6): 541-4, 2012 Jun.
Article
in Sr
| MEDLINE | ID: mdl-22779303
Results
1 -
19
de 19
1
Next >
>>